Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles

被引：6
作者：
Lin, Hung-Yao [1 ]
Tseng, Tai-Chung [1 ,2 ,3 ]
机构：
[1] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Med Res, 1 Chang Te St, Taipei 10002, Taiwan
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2022年 / 28卷 / 02期
关键词：
Tenofovir disoproxil fumarate; Tenofovir alafenamide; Hyperlipidemias; Tenofovir;
D O I：
10.3350/cmh.2022.0028
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [31] Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence
    Byrne, Ruth
    Carey, Ivana
    Agarwal, Kosh
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2018, 11
  • [32] Kinetics of the hepatitis B core-related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide
    Itokawa, Norio
    Atsukawa, Masanori
    Tsubota, Akihito
    Ishikawa, Toru
    Toyoda, Hidenori
    Takaguchi, Koichi
    Watanabe, Tsunamasa
    Ogawa, Chikara
    Hiraoka, Atsushi
    Okubo, Hironao
    Uojima, Haruki
    Chuma, Makoto
    Nozaki, Akito
    Kato, Keizo
    Mikami, Shigeru
    Tani, Joji
    Morishita, Asahiro
    Tada, Toshifumi
    Asano, Toru
    Senoh, Tomonori
    Oikawa, Tsunekazu
    Okubo, Tomomi
    Kumada, Takashi
    Iwakiri, Katsuhiko
    HEPATOLOGY RESEARCH, 2024, 54 (11) : 993 - 1003
  • [33] Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B
    Ogawa, Eiichi
    Nomura, Hideyuki
    Nakamuta, Makoto
    Furusyo, Norihiro
    Koyanagi, Toshimasa
    Dohmen, Kazufumi
    Ooho, Aritsune
    Satoh, Takeaki
    Kawano, Akira
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Azuma, Koichi
    Kato, Masaki
    Shimoda, Shinji
    Hayashi, Jun
    LIVER INTERNATIONAL, 2020, 40 (07) : 1578 - 1589
  • [34] Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogs
    Yamashige, Daiki
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Kobayashi, Masahiro
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (11) : 1008 - 1021
  • [35] Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogs
    Daiki Yamashige
    Tetsuya Hosaka
    Fumitaka Suzuki
    Shunichiro Fujiyama
    Yusuke Kawamura
    Hitomi Sezaki
    Norio Akuta
    Masahiro Kobayashi
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Hiromitsu Kumada
    Journal of Gastroenterology, 2021, 56 : 1008 - 1021
  • [36] Comparison of Tenofovir Alafenamide and Entecavir Therapy in Patients with Chronic Hepatitis B Initially Treated with Tenofovir Disoproxil: A Retrospective Observational Survey
    Kalkan, Irem Akdemir
    Karasahin, Omer
    Sarigul, Figen
    Toplu, Sibel Altunisik
    Aladag, Murat
    Akgul, Fethiye
    Mete, Ayse Ozlem
    Golbol, Abdullah
    Nazik, Selcuk
    Komur, Suheyla
    Oren, Meryem Merve
    Yildiz, Yesim
    Demir, Yakup
    Ayhan, Merve
    Tasova, Yesim
    Bayindir, Yasar
    Dal, Tuba
    Celen, Mustafa K.
    HEPATITIS MONTHLY, 2021, 21 (10)
  • [37] Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B
    Cheng, Pin-Nan
    Feng, I-Cher
    Chen, Jyh-Jou
    Kuo, Hsing-Tao
    Lee, Pei-Lun
    Yu, Ming-Lung
    Chiu, Yen-Cheng
    Chiu, Hung-Chih
    Chien, Shih-Chieh
    Chen, Pei-Jer
    Liu, Chun-Jen
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 230 - 238
  • [38] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1083 - 1092
  • [39] Tenofovir amibufenamide vs tenofovir alafenamide for treating chronic hepatitis B: A real-world study
    Peng, Wen-Ting
    Jiang, Chuan
    Yang, Fei-Lan
    Zhou, Nian-Qi
    Chen, Ke-Yu
    Liu, Jin-Qing
    Peng, Shi-Fang
    Fu, Lei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (44) : 5907 - 5918
  • [40] Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B
    Jung, Chan-Young
    Kim, Hyung Woo
    Ahn, Sang Hoon
    Kim, Seung Up
    Kim, Beom Seok
    LIVER INTERNATIONAL, 2022, 42 (05) : 1017 - 1026
12345